Skip to content
AwardedRomaniaGoodsRON 40,661

Reactivi si consumabile medicale CANTAVAC 2.0

Published
Published 13 April 2026
Deadline
Closed 21 May 2026

Overview

The National Institute for Research and Development in Pathology and Biomedical Sciences Victor Babes procured reactants required for the translational research project CANTAVAC 2.0 on vaccine, serum, and biological medicine development, divided into 2 lots comprising 20 products totaling 73 units. The contract was awarded on 19 June 2026 to HYPO TECH & CONSULTING SRL and S.C. REDOX RESEARCH & ANALYTIC S.R.L. for 40,390 RON.

Key details

Country
Romania
Status
Awarded
Category
Goods
Estimated value
RON 40,661
Procedure
Open
Published
13 April 2026
Deadline
Closed
Classification (CPV)
Chemical reagentsLaboratory reagents

Award outcome

Awarded value
RON 40,390
Award date
19 June 2026
Contract period
— → 16 December 2026
Winners
  • HYPO TECH & CONSULTING SRL
  • S.C. REDOX RESEARCH & ANALYTIC S.R.L. S.R.L.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    26 June 2026

  2. Contract Notice

    13 April 2026

Contracting authority

  • Institutul National de Cercetare Dezvoltare in Domeniul Patologiei si Stiintelor Biomedicale Victor Babes

    Procuring entity

    Bucuresti, Romania

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Reactivi si consumabile medicale CANTAVAC 2.0 — won by HYPO TECH & CONSULTING SRL +1 — Skim